A detailed history of First American Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First American Bank holds 30,209 shares of GILD stock, worth $2.53 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
30,209
Previous 30,674 1.52%
Holding current value
$2.53 Million
Previous $2.23 Million 92968.61%
% of portfolio
0.16%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$63.15 - $72.88 $29,364 - $33,889
-465 Reduced 1.52%
30,209 $2.07 Billion
Q4 2023

Jul 31, 2024

SELL
$73.27 - $83.09 $23,812 - $27,004
-325 Reduced 1.06%
30,209 $2.45 Million
Q3 2023

Jul 31, 2024

BUY
$73.94 - $80.67 $29,280 - $31,945
396 Added 1.31%
30,534 $2.29 Million
Q1 2023

Jul 31, 2024

SELL
$77.31 - $88.08 $41,360 - $47,122
-535 Reduced 1.74%
30,138 $2.5 Million
Q4 2022

Jul 31, 2024

BUY
$62.32 - $89.47 $6,294 - $9,036
101 Added 0.33%
30,673 $2.63 Million
Q3 2022

Jul 31, 2024

BUY
$59.54 - $68.01 $7,859 - $8,977
132 Added 0.43%
30,572 $1.89 Million
Q2 2022

Jul 31, 2024

SELL
$57.72 - $65.01 $13,506 - $15,212
-234 Reduced 0.76%
30,440 $1.88 Million
Q1 2022

Jul 31, 2024

BUY
$57.92 - $72.58 $26,932 - $33,749
465 Added 1.54%
30,674 $1.82 Million
Q3 2021

Oct 28, 2021

SELL
$67.69 - $73.03 $50,090 - $54,042
-740 Reduced 2.36%
30,674 $2.14 Million
Q2 2021

Jul 13, 2021

SELL
$63.47 - $69.35 $21,262 - $23,232
-335 Reduced 1.06%
31,414 $2.16 Million
Q1 2021

Apr 08, 2021

SELL
$60.0 - $68.46 $15,660 - $17,868
-261 Reduced 0.82%
31,749 $2.05 Million
Q4 2020

Jan 06, 2021

SELL
$56.65 - $64.55 $900,904 - $1.03 Million
-15,903 Reduced 33.19%
32,010 $1.87 Million
Q3 2020

Oct 09, 2020

SELL
$62.1 - $78.08 $1,242 - $1,561
-20 Reduced 0.04%
47,913 $3.03 Million
Q1 2020

Apr 07, 2020

SELL
$62.63 - $80.22 $1.34 Million - $1.72 Million
-21,405 Reduced 30.87%
47,933 $3.58 Million
Q4 2019

Jan 24, 2020

BUY
$61.62 - $67.78 $4.27 Million - $4.7 Million
69,338 New
69,338 $4.51 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track First American Bank Portfolio

Follow First American Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First American Bank, based on Form 13F filings with the SEC.

News

Stay updated on First American Bank with notifications on news.